Regulation of Lysyl Oxidase-like 1 (LOXL1) and Elastin-Related Genes by Pathogenic Factors Associated with Pseudoexfoliation Syndrome

PURPOSE. Pseudoexfoliation (PEX) syndrome/glaucoma is a complex, late-onset disorder of the elastic fiber system. Strong genetic risk is conferred by the lysyl oxidase-like 1 (LOXL1) gene, but additional comodulating factors are necessary for the manifestation of the disease. The aim of this study was to analyze the effect of various PEX-associated pathogenic factors on the genotype-correlated expression of LOXL1 and elastin-related genes. METHODS. Cultured human Tenon's capsule fibroblasts with high-and low-risk LOXL1 haplotypes were exposed to transforming growth factor (TGF)-beta 1, interleukin (IL)-6, homocysteine, oxidative stress, hypoxia, or ultraviolet (UV) radiation. Changes in the expression of LOXL1 and elastic constituents of PEX material and TGF-beta 1 were assessed by quantitative real-time PCR, Western blotting, immunohistochemistry, and electron microscopy. RESULTS. Treatment of fibroblasts with TGF-beta 1, oxidative stress, UV light, and hypoxia induced a significant increase in expression levels of LOXL1 and elastic proteins, whereas the effect of IL-6 was limited to induction of elastic constituents. Immunohistochemistry and electron microscopy confirmed an upregulation of LOXL1 and elastic fiber proteins and their assembly into extracellular microfibrillar networks with focal aggregation of microfibrils into PEX-like fibrils on stimulation with TGF-beta 1 and oxidative stress. Basal and stimulated expression of LOXL1 mRNA and protein was slightly decreased in cells carrying the high-risk compared with the low-risk haplotype of LOXL1, but the differences between groups were statistically not significant. CONCLUSIONS. The findings support the notion that both genetic and nongenetic fibrogenic factors, particularly TGF-beta 1 and oxidative stress, may cooperate in the stable accumulation of PEX aggregates. (Invest Ophthalmol Vis Sci. 2011;52:8488-8495) DOI:10.1167/iovs.11-8361